Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG). (Q47832940)
Jump to navigation
Jump to search
scientific article published on 7 March 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG). |
scientific article published on 7 March 2017 |
Statements
1 reference
Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG). (English)
1 reference
Peter Hohenberger
Bernd Kasper
Viktor Gruenwald
Peter Reichardt
Geraldine Rauch
Ronald Limprecht
Michaela Sommer
Lothar Pilz
7 March 2017
1 reference